NGNE — Neurogene Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual balance sheet for Neurogene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	193	142	96.4	197	312
Net Total Accounts Receivable
Net Total Receivables	0.9	—	—	—	0.648
Prepaid Expenses
Total Other Current Assets
Total Current Assets	195	144	99.1	200	316
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.7	17.2	15.9	21	18.5
Net Intangible Assets
Other Long Term Assets
Total Assets	211	163	116	223	336
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.89	8.64	11.1	23	15.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.3	20.4	21.6	36.5	25.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	191	143	94.3	186	310
Total Liabilities & Shareholders' Equity	211	163	116	223	336
Total Common Shares Outstanding